SMAD9 and osteoporosis: A study on zebrafish helped to unravel the role of Smad9 as a downstream inhibitor of the BMP signaling pathway and reducer of osteoblast activity, providing evidence that Smad9 can be used as anabolic target for the treatment of osteoporosis.